Sun R, Liu K, Pan S, Ye Y, et al. LRP4 mutations promote tumour progression and resistance to anti-PD-1 therapy in recurrent hepatocellular carcinoma. Hepatology 2024 Dec 24. doi: 10.1097/HEP.0000000000001212.
PMID: 39723987